Cytotoxicity analysis of oxazine 4-perchlorate fluorescence nerve potential clinical biomarker for guided surgery

Sandra Pampín-Suárez1, José Luis Arce-Diego1, Olga Tapia2

  • 1Biomedical Engineering Group, TEISA Department, University of Cantabria, Avenida de los Castros 46, 39005 Santander, Spain.

Biomedical Optics Express
|February 14, 2022
PubMed

Insights

Oxazine 4-perchlorate (O4P) shows promise for nerve identification in surgery. Concentrations below 100 µM are safe for U87 glioma cells, supporting its potential as a nerve biomarker.

Area of Science:

  • Biomedical optics
  • Surgical technology
  • Cellular toxicology

Background:

  • Accurate nerve identification is crucial in guided surgery to prevent collateral damage.
  • Fluorescence imaging using oxazine 4-perchlorate (O4P) is a potential method for nerve visualization.
  • Assessing the safety and efficacy of novel biomarkers is essential for clinical translation.

Purpose of the Study:

  • To evaluate the cytotoxicity of oxazine 4-perchlorate (O4P) on U87 human-derived glioma cells.
  • To determine the safety of O4P under various operating room irradiation conditions.
  • To investigate the potential of O4P as a nerve biomarker in surgical applications.

Main Methods:

  • Cytotoxicity assays were performed on U87 glioma cells exposed to varying concentrations of O4P.
  • Cells were subjected to different optical irradiation modes using a custom-built device for controlled dosimetry.
  • Immunofluorescence and confocal microscopy were utilized to assess DNA damage and O4P intracellular localization.

Main Results:

  • O4P exhibited no significant cytotoxicity on U87 glioma cells at concentrations below 100 µM.
  • Intracellular localization and DNA damage were analyzed under different irradiation conditions.
  • The study established a safe concentration threshold for O4P in a cellular model.

Conclusions:

  • Oxazine 4-perchlorate (O4P) demonstrates a favorable safety profile at concentrations below 100 µM for U87 glioma cells.
  • These findings support the feasibility of using O4P as a nerve biomarker in guided surgery.
  • Further research is warranted to validate O4P's efficacy and safety in vivo for surgical applications.